Diagnosis of herpes simplex virus infections of the CNS.
Advances in the diagnosis of herpes simplex virus infections of the CNS have occurred rapidly over the past 10 years. The development and application of PCR technology to the detection of herpes simplex virus DNA from cerebrospinal fluid has resulted in tremendous improvements in the management of patients with suspected herpes simplex virus CNS infections, not the least of which is decreasing the necessity for invasive brain biopsy to establish the diagnosis. The pace of discovery has continued in recent years with the development of more rapid DNA amplification techniques that do not require postamplification analysis using amplified products (real-time PCR). However, despite the power of these new diagnostic modalities, test results must always be considered in the context of the patient, and physician judgment should never be usurped by technological advances. This article will summarize the advances in the diagnosis of herpes simplex virus CNS disease within the context of how these advances can enhance the care of individual patients.
Kimberlin
David W
DW
Division of Pediatric Infectious Diseases, The University of Alabama, 1600 Seventh Avenue South, CHB 303, Birmingham, AL 35233, USA. dkimberlin@peds.uab.edu
D000818:Animals; D002490:Central Nervous System / Q000378:metabolism / Q000473:pathology / Q000821:virology*; D006561:Herpes Simplex / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy / Q000821:virology*; D006801:Humans; D012307:Risk Factors; D018139:Simplexvirus / Q000302:isolation & purification / Q000502:physiology*; D016896:Treatment Outcome